Sana Biotechnology, Inc. (SANA) stock
SANANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.88+0.00 (0.00%)
Close on Nov 17, 2026Market cap $562.80MP/E –Yield –
Sana Biotechnology enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Sana Biotechnology's enterprise value was $524.92M on Nov 11, 2026, against $970.49M a year earlier. Over the last 5 years it ranged from $160.83M to $2.22B, with a median of $716.89M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $524.92M | -42.3% |
| 2025 | Dec 31, 2025 | $910.17M | +465.9% |
| 2024 | Dec 31, 2024 | $160.83M | -69.7% |
| 2023 | Dec 29, 2023 | $531.62M | +109.5% |
| 2022 | Dec 30, 2022 | $253.79M | -88.6% |
| 2021 | Dec 31, 2021 | $2.22B | – |
See a number that looks wrong?